Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Correction: Scribble mis-localization drives adaptive resistance to KRAS G12C inhibitors via YAP-induced MRAS and feedback activation of MAPK signaling
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.